SOCS3 is a well-known feedback inhibitor of the Janus kinases-signal transducer and activator of transcription 3 signaling pathway [31], implying that during MDD remission, there would be a tendency for inflammatory cytokines to be produced due to a decrease in SOCS3 mRNA. The gene discussed is SOCS3; the disease is major depressive disorder.